review Open AccessTop 1% cited
Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges
Cell stem cell · 2020 · Vol. 27(4) · pp. 523–531
Shinya Yamanaka✉(Gladstone Institutes)
Pluripotent Stem Cells ResearchCRISPR and Genetic EngineeringBiomedical Ethics and RegulationBiologyInduced pluripotent stem cellStem cellCell therapyCellCell biologyComputational biologyEmbryonic stem cellGeneticsGene
MeSH terms
HumansStem Cell TransplantationPluripotent Stem CellsEmbryonic Stem CellsInduced Pluripotent Stem CellsCell- and Tissue-Based Therapy
Funding
- Japan Agency for Medical Research and Development
Citations
1,177
FWCI
50.06
field-weighted impact
References
80
Percentile
100%
vs. same field & year
Citations per year
References
Stage-Specific Optimization of Activin/Nodal and BMP Signaling Promotes Cardiac Differentiation of Mouse and Human Pluripotent Stem Cell Lines
Cell stem cell · 2011 · 1,171 citations
Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells
Current Biology · 2001 · 868 citations
Embryonic Stem Cell Lines Derived from Human Blastocysts
Science · 1998 · 15,836 citations
CNS immune privilege: hiding in plain sight
Immunological Reviews · 2006 · 779 citations
Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency
Cell stem cell · 2014 · 888 citations
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
Cell · 2006 · 26,294 citations
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Cell · 2007 · 20,020 citations
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Science · 2007 · 10,216 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.